HSR21-062: Real-World Study of BRCA1/2 Mutation (BRCA1/2mut) Testing Among Adult Patients (pts) With HER2− Advanced Breast Cancer (ABC) in the US

Authors: Reshma Mahtani DO1, Alex Niyazov PharmD2, MPH; Katie Lewis BSc3, Lucy Massey BSc3, Alex Rider BSc3, Bhakti Arondekar PhD, MBA2, and Michael Lux Prof, Dr, med, MBA4
View More View Less
  • 1 Sylvester Cancer Center, University of Miami, Deerfield Beach, FL
  • | 2 Pfizer Inc., New York, NY
  • | 3 Adelphi Real World, Bollington, UK
  • | 4 Kooperatives Brustzentrum Paderborn; Frauenklinik St. Louise, Paderborn; St. Josefs-Krankenhaus, Salzkotten; and Frauen- und Kinderklinik St. Louise, Paderborn, Germany
Restricted access

Disclosures: ML reports honoraria for lectures, consulting or advisory role for Eli Lilly, AstraZeneca, MSD, Novartis, Pfizer, Eisai, Exact Sciences, Roche, Hexal and Medac; travel, accommodations, expenses from Roche and Pfizer; editorial board member of Medac; fees for non-CME services from Eli Lilly, Roche, Novartis, Pfizer, Exact Sciences, AstraZeneca, MSD, and Eisai.

Funding: Pfizer

Corresponding Author: Katie Lewis, BSc
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 126 126 6
PDF Downloads 130 130 1
EPUB Downloads 0 0 0